Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Product Information [Line Items]    
Revenue recognition percentage 100.00%  
Certificates of deposit fair value $ 18,653,000 $ 22,929,000
Unrecognized tax benefits $ 4,843,000  
Net amount at risk by product and guarantee, weighted average period remaining 1 year 8 months 12 days  
Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]    
Product Information [Line Items]    
Concentration risk, percentage   100.00%
Warrant [Member]    
Product Information [Line Items]    
Antidilutive securities excluded from the calculation of Diluted EPS 300,000 300,000
Equity Option [Member]    
Product Information [Line Items]    
Expiration period 5 years 10 years
Antidilutive securities excluded from the calculation of Diluted EPS 12,158,062 11,430,000
Equity Option [Member] | Minimum [Member]    
Product Information [Line Items]    
Vesting period 12 months 12 months
Equity Option [Member] | Maximum [Member]    
Product Information [Line Items]    
Vesting period 36 months 36 months
Employees and directors [Member]    
Product Information [Line Items]    
Stock-based compensation expense $ 4,420,000 $ 4,422,000
Stock-based consulting expense 3,187,000 3,023,000
Consultants[Member] | Service based and performance based stock options [Member]    
Product Information [Line Items]    
Stock-based consulting expense 125,000 221,000
Stock options granted to consultants $ 180,000  
Weighted-average period recognition 1 year 10 months 24 days  
Consultants[Member] | Non vested stock option[Member]    
Product Information [Line Items]    
Stock-based consulting expense $ 120,000 $ 209,000